IMR Press / CEOG / Volume 6 / Issue 4 / pii/1634267383413-32912509

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Inhibition of lactation by prostaglandin E2
Show Less
1 Department of Obstetrics and Gynecology, University of Cagliari
Clin. Exp. Obstet. Gynecol. 1979, 6(4), 255–259;
Published: 10 December 1979
Abstract

Prostaglandin E2 was given orally to twenty puerperal women during the fourth and the fifth·day after delivery. The milk secretion disappeared in all cases within 48 hours from the·beginning of treatment and the prolactin plasma levels showed a significant decrease (P < 0.001) already during the Prostaglandin E2 administration. The results can be explained by a Prostaglandin E2 and prolatin decrease inhibitory effect on breast metabolism.
Share
Back to top